Insider filing · BBIO
Randal W. Scott
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Randal W. Scott sold $666K of BridgeBio Pharma (BBIO)
Executed Nov 17 2025, disclosed Nov 19 2025, 2 days later.
Value, as filed
$666K
10,000 sh across 2 lots
Executed
Nov 17 2025
the trade date, as filed
Disclosed
Nov 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RSRandal W. Scott (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $755K of BBIO (10,000 sh across 3 lots, as filed), executed Feb 17.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Randal W. Scott in BBIO
BBIOSALE
BridgeBio Pharma, Inc.
$658K9,800 sh across 3 lots
Exec May 15
Filed May 19 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $755K
10,000 sh across 3 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET